Thus, a molecule that could regulate the production and secretion of lipocalin-2 might ameliorate the deteriorated endothelial and metabolic dysfunctions induced by obesity, and finally contribute to the amelioration of obesity-accompanied hypertension. Here, LCN2 is linked to obesity disorder.